Dayton M. Petibone
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2011–2025); Wayne State University (2007–2010)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Dayton M. Petibone's research investigates genotoxicity and carcinogenic outcomes. This work includes evaluating the potential value of animal microphysiological systems for drug development and assessing whether available data are sufficient to inform risk assessment for DNA-reactive drugs. Publications also explore the in vitro effects of compounds like cannabidiol and black cohosh extract on mammalian cells, examining potential genotoxic mechanisms.
Petibone's scholarship includes 33 publications, with 771 citations and an h-index of 14. Key collaborators include Donna L. Mendrick, Volodymyr Tryndyak, Nan Mei, and Mugimane G. Manjanatha, all affiliated with the National Center for Toxicological Research. Recent work has focused on considerations for animal microphysiological systems in drug development, aligning with the 3Rs principles (Replacement, Reduction, Refinement) in animal research.
Metrics
- h-index: 14
- Publications: 33
- Citations: 797
Selected Publications
-
Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment? (2025)
-
Considerations from the pharmaceutical industry (IQ MPS affiliate) workshop on animal microphysiological systems and 3Rs in drug development (2025)
-
Potential value of animal microphysiological systems (2024)
-
In vitro effects of cannabidiol and its main metabolites in mouse and human Sertoli cells (2021)
-
Mechanistic Evaluation of Black Cohosh Extract-Induced Genotoxicity in Human Cells (2021)
-
Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessment (2020)
-
Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research (2019)
-
Quantification of cellular associated graphene and induced surface receptor responses (2019)
-
Analysis of mutation in the rat Pig‐a assay: I) studies with bone marrow erythroid cells (2018)
-
Analysis of mutation in the rat Pig‐a assay: II. Studies with bone marrow granulocytes (2018)
-
Fluorescence In Situ Hybridization in Genotoxicity Testing (2017)
-
In Vivo Rat T-Lymphocyte Pig-a Assay: Detection and Expansion of Cells Deficient in the GPI-Anchored CD48 Surface Marker for Analysis of Mutation in the Endogenous Pig-a Gene (2017)
-
p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity (2017)
-
Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity (2016)
-
The role of surface chemistry in the cytotoxicity profile of graphene (2016)
Collaboration Network
Top Collaborators
- In vivo genotoxicity of furan in F344 rats at cancer bioassay doses
- Pubertal delay in male nonhuman primates ( Macaca mulatta ) treated with methylphenidate
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines
- The genetic toxicity of methylphenidate: a review of the current literature
Showing 5 of 7 shared publications
- Confirmation of Pig-a mutation in flow cytometry-identified CD48-deficient T-lymphocytes from F344 rats
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines
- In Vivo Rat T-Lymphocyte Pig-a Assay: Detection and Expansion of Cells Deficient in the GPI-Anchored CD48 Surface Marker for Analysis of Mutation in the Endogenous Pig-a Gene
- Analysis of mutation in the rat Pig‐a assay: I) studies with bone marrow erythroid cells
Showing 5 of 6 shared publications
- Confirmation of Pig-a mutation in flow cytometry-identified CD48-deficient T-lymphocytes from F344 rats
- Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines
- In Vivo Rat T-Lymphocyte Pig-a Assay: Detection and Expansion of Cells Deficient in the GPI-Anchored CD48 Surface Marker for Analysis of Mutation in the Endogenous Pig-a Gene
- Analysis of mutation in the rat Pig‐a assay: I) studies with bone marrow erythroid cells
- Analysis of mutation in the rat Pig‐a assay: II. Studies with bone marrow granulocytes
- In vivo genotoxicity of furan in F344 rats at cancer bioassay doses
- Confirmation of Pig-a mutation in flow cytometry-identified CD48-deficient T-lymphocytes from F344 rats
- Analysis of mutation in the rat Pig‐a assay: I) studies with bone marrow erythroid cells
- Analysis of mutation in the rat Pig‐a assay: II. Studies with bone marrow granulocytes
- Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine
- The role of surface chemistry in the cytotoxicity profile of graphene
- Quantification of cellular associated graphene and induced surface receptor responses
- Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research
- In vivo genotoxicity of furan in F344 rats at cancer bioassay doses
- In Vivo Rat T-Lymphocyte Pig-a Assay: Detection and Expansion of Cells Deficient in the GPI-Anchored CD48 Surface Marker for Analysis of Mutation in the Endogenous Pig-a Gene
- Analysis of mutation in the rat Pig‐a assay: II. Studies with bone marrow granulocytes
- Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research
- Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity
- The role of surface chemistry in the cytotoxicity profile of graphene
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- Quantification of cellular associated graphene and induced surface receptor responses
- Pubertal delay in male nonhuman primates ( Macaca mulatta ) treated with methylphenidate
- The genetic toxicity of methylphenidate: a review of the current literature
- Evaluation of p53 genotype on gene expression in the testis, liver, and heart from male C57BL/6 mice
- Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine
- The role of surface chemistry in the cytotoxicity profile of graphene
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- In vivo genotoxicity of furan in F344 rats at cancer bioassay doses
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- Fluorescence In Situ Hybridization in Genotoxicity Testing
- Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity
- The role of surface chemistry in the cytotoxicity profile of graphene
- Quantification of cellular associated graphene and induced surface receptor responses
- The role of surface chemistry in the cytotoxicity profile of graphene
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- Quantification of cellular associated graphene and induced surface receptor responses
- The role of surface chemistry in the cytotoxicity profile of graphene
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- Quantification of cellular associated graphene and induced surface receptor responses
- The role of surface chemistry in the cytotoxicity profile of graphene
- p53‐competent cells and p53‐deficient cells display different susceptibility to oxygen functionalized graphene cytotoxicity and genotoxicity
- Quantification of cellular associated graphene and induced surface receptor responses
- Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessment
- Analysis of mutation in the rat Pig‐a assay: I) studies with bone marrow erythroid cells
- Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?
Similar Researchers
Based on overlapping research topics